Canadian consensus statement on HIV and its transmission in the context of criminal law

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 25, Issue 3, 2014, Pages 135-140

  Loutfy, Mona ^a   Tyndall, Mark ^b   Baril, Jean Guy ^c   Montaner, Julio S G ^d   Kaul, Rupert ^e   Hankins, Catherine ^f  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Chronic manageable condition; Consensus statement; Criminal law; HIV risks of transmission

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANAL PENILE INTERCOURSE; BITE; CONDOM USE; CONFERENCE PAPER; CONSENSUS; CRIMINAL LAW; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MEDICAL EXPERT; ORAL SEX; RESPONSIBILITY; SEXUAL INTERCOURSE; SEXUAL TRANSMISSION; VAGINAL PENILE INTERCOURSE; VIRUS LOAD;

EID: 84903577154     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2014/498459     Document Type: Conference Paper

References (17)

1. Anglemyer A, Rutherford GW, Egger M, Siegfried N. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane Database Syst Rev 2011;10:CD009153. 〈http://apps.who.int/rhl/reviews/CD009153. pdf〉
2. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: A collaborative analysis of 14 cohort studies. Lancet 2008;372:293-9.
3. Baggaley RF, White RG, Boily MC. Systematic review of orogenital HIV 1 transmission probabilities. Int J Epidemiol 2008;37:1255-65. 〈http://ije.oxfordjournals.org/content/37/6/1255〉
4. Baggaley RF, White RG, Boily MC. HIV transmission risk through anal intercourse: Systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol 2010;39:1048-63. 〈http://ije.oxfordjournals. org/content/39/4/1048.full〉
5. Baggaley RF, White RG, Hollingsworth TD, Boily MC. Heterosexual HIV-1 infectiousness and antiretroviral use: Systematic review of prospective studies of discordant couples. Epidemiology 2013;24:110-21.
6. Boily MC, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: Systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009;9:118-29.
7. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493-505. 〈http://www.nejm.org/doi/full/10.1056/NEJMoa1105243〉
8. Crum NF, Riffenburgh RH, Wegner S, et al Triservice AIDS Clinical Consortium. Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr 2006;41:194-200.
9. Jin F, Jansson J, Law M, et al. Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS 2010;24:907-13. 〈http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852627/〉
10. Loutfy MR, Wu W, Letchumanan L, et al. Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV positive partner is fully suppressed on antiretroviral therapy. PLoS ONE 2013;8:e55747. 〈http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572113/〉
11. Nakagawa F, Lodwick RK, Smith CJ, et al. Projected life expectancy of people with HIV according to timing of diagnosis. AIDS 2012;26:335-43.
12. Nakagawa F, May M, Phillips A. Life expectancy living with HIV: Recent estimates and future implications. Curr Opin Infect Dis 2013;26:17-25.
13. Powers KA, Poole C, Pettifor AE, Cohen MS. Rethinking the heterosexual infectivity of HIV-1: A systematic review and metaanalysis. Lancet Infect Dis 2008;8:553-63. 〈http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744983/〉
14. Rodger AJ, Lodwick R, Schechter M, et al INSIGHT SMART, ESPRIT Study Groups. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS 2013;27:973-9. 〈http://journals.lww.com/aidsonline/ documents/mortality-in-well-controlled-HIV-QAD-27-6.pdf〉
15. Samji H, Cescon A, Hogg RS et al. Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS ONE 2013;8:e81355 〈http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3867319/〉
16. Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol 1999;150:306-11. 〈http://aje. oxfordjournals.org/content/150/3/306.long〉
17. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2002;1:CD003255. 〈http://apps.who. int/rhl/reviews/CD003255.pdf〉